Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.5M Buy
88,509
+5,022
+6% +$1.36M 0.18% 106
2025
Q4
$24.7M Buy
83,487
+5,341
+7% +$1.6M 0.23% 94
2025
Q3
$22M Buy
78,146
+8,389
+12% +$2.2M 0.21% 102
2025
Q2
$20.6M Sell
69,757
-17,269
-20% -$4.45M 0.23% 99
2025
Q1
$21.6M Buy
87,026
+30,651
+54% +$7.5M 0.32% 71
2024
Q4
$12.4M Buy
56,375
+17,282
+44% +$3.85M 0.22% 102
2024
Q3
$8.64M Buy
39,093
+15,072
+63% +$2.96M 0.22% 90
2024
Q2
$4.15M Buy
24,021
+1,596
+7% +$277K 0.11% 176
2024
Q1
$4.28M Sell
22,425
-1,116
-5% -$204K 0.09% 231
2023
Q4
$3.85M Buy
23,541
+43
+0.2% +$6.5K 0.1% 230
2023
Q3
$3.3M Buy
+23,498
New +$3.34M 0.1% 202

Other funds holding IBM

Vident Advisory's IBM Position: Q1 2026 in Review

Vident Advisory increased its IBM (IBM) stake by 6% in Q1 2026, buying an estimated $1.36M and bringing the position to 88,509 shares worth $21.5M. The position accounts for 0.18% of the portfolio, ranked #106.

Vident Advisory first reported a position in IBM in Q3 2023 and has held it in 11 quarters since. The position peaked at $24.7M in Q4 2025. 3,462 funds tracked by Wall St. Rank hold IBM as of Q1 2026.

  • Vident Advisory held 88,509 shares of IBM worth $21.5M as of Q1 2026.
  • Vident Advisory bought 5,022 IBM shares in Q1 2026, an estimated $1.36M.
  • IBM made up 0.18% of Vident Advisory's portfolio in Q1 2026, its #106 holding.
  • Vident Advisory first reported a position in IBM in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's IBM position peaked at $24.7M in Q4 2025.
  • 3,462 funds tracked by Wall St. Rank held IBM as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.